Product has patent protection through 2044 - - Expected to be listed in the U.S. Food and Drug Administration’s (FDA) Orange Book upon the ...

Eton Pharmaceuticals (ETON) announced that the United States Patent and Trademark Office has granted the company U.S. Patent No. 12,214,010, ...

The Federal Circuit heard oral argument in Auribundo's appeal of the district court's decision in favor of plaintiff Merck, ...

Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on ...

Stifel analysts have maintained a Buy rating and a $28.00 price target for Phathom Pharmaceuticals (NASDAQ:PHAT), focusing on the company's recent developments. Currently trading at $5.59, ...

Q4 2024 Earnings Call Transcript February 7, 2025 Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.12 ...

The authorities could allow the country’s currency, the peso, to weaken against the dollar, effectively making its exports ...

Appellate courts issued a variety of notable intellectual property (IP) cases in 2024, including cases touching on Orange Book ...

No Chance to Surrender Sometimes some of the best proof of something or someone’s essence is found in one of its more forgotten manifestations. I spent ...

In the coming years, an unprecedented number of people will leave planet Earth—but it’s becoming increasingly clear that deep ...